Major role for ICDs (implantable cardioverter defibrillator) in reducing cardiac death
This article was originally published in Clinica
Executive Summary
A significant US and Canadian trial has provided compelling evidence that patients with coronary artery disease (CAD) who are at risk of cardiac death would be better off receiving an implantable defibrillator rather than the commonly-used anti-arrhythmic drugs.